
Transactions: Healthcare
Filter


Directed new share issue in Oncopeptides AB (SE) — SEK 314 million

Divestment of Frösunda Omsorg AB (SE) to Adolfsen Group (NO) by HgCapital (UK) — Amount not disclosed

Divestment of Med Group (FI) to Colosseum Dental Group (CH) and Tradeka (FI) by Adelis Equity Partners (SE) — Amount not disclosed

Directed new share issue in Medivir AB (SE) — SEK 155 million

Directed new share issue in Wilson Therapeutics AB (SE) — SEK 244 million

Initial public offering of Orphazyme (DK) on Nasdaq Copenhagen — DKK 600 million

Initial public offering of BioArctic AB (SE) on Nasdaq Stockholm – SEK 805 million

Initial public offering of Handicare Group AB (SE) on Nasdaq Stockholm — SEK 983 million

Initial public offering of Terveystalo Oyj (FI) on Nasdaq Helsinki — EUR 876 million

Sale of a 40% minority stake in Dr. Fürst Medisinsk Laboratorium (NO) to Ferd Capital (NO) — Amount not disclosed
